Affirm Holdings, Inc. expected to post earnings of 34 cents a share - Earnings Preview
Affirm Holdings, Inc. expected to post earnings of 34 cents a share - Earnings Preview
Affirm Holdings, Inc. AFRM.OQ AFRM.O is expected to show a rise in quarterly revenue when it reports results on August 27 for the period ending June 30 2026
The San Francisco California-based company is expected to report a 26.2% increase in revenue to $1.106 billion from $876.42 million a year ago, according to the mean estimate from 28 analysts, based on LSEG data.
LSEG's mean analyst estimate for Affirm Holdings, Inc. is for earnings of 34 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 26 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Affirm Holdings, Inc. is $90.00, about 15.5% above its last closing price of $77.95
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.19 | 0.19 | 0.30 | Beat | 56.6 |
Dec. 31 2026 | 0.26 | 0.26 | 0.37 | Beat | 41.9 |
Sep. 30 2025 | 0.11 | 0.11 | 0.23 | Beat | 114.7 |
Jun. 30 2025 | 0.11 | 0.11 | 0.20 | Beat | 87.6 |
Mar. 31 2025 | -0.01 | -0.03 | 0.01 | Beat | 134.3 |
Dec. 31 2024 | -0.12 | -0.15 | 0.23 | Beat | 252.8 |
Sep. 30 2024 | -0.31 | -0.34 | -0.31 | Beat | 9.4 |
Jun. 30 2024 | -0.44 | -0.51 | -0.14 | Beat | 72.6 |
This summary was machine generated August 25 at 23:01 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Affirm Holdings
See all newsBrief: Affirm Holdings Announces Exclusive Multi-Year Pay-Over-Time Collaboration With Sam's Club
U.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
Street View: Affirm soars after revenue forecast exceeds estimates
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna